Most founders think the first term sheet is just a gateway to “real work.” You sign it, you build, you raise again. Simple.
But some clauses in that first term sheet do not stay small. They sit quietly in the corners. Then, in your next round, they wake up and start taking time, leverage, and options away from you—right when you need speed and clean terms the most.
This matters even more for deep tech, robotics, and AI startups, where your value is often in what you built that others cannot copy. Your IP, your patents, your data, your methods. If your early paperwork creates doubt, or gives someone hidden control, later investors will slow down or reduce price. Sometimes they walk.
This article will show you the term sheet clauses that look normal but often cause pain later. The goal is not to make you scared. The goal is to help you spot problems early and fix them while you still can.
And if you want help setting your company up so future rounds feel easier—not harder—Tran.vc can help you build an IP foundation from day one. You can apply anytime here: https://www.tran.vc/apply-now-form/
The quiet truth about later rounds
Later rounds are not only about growth. They are also about “clean.” Clean cap table. Clean ownership. Clean rights. Clean IP. Clean decision paths.
A Series A lead investor is not only buying your story. They are buying a structure they can trust. If something in your seed terms creates friction, they will try to remove it. Removal usually costs time and money. And it often forces you to renegotiate with people who have no reason to say yes unless you pay them.
So the key is to avoid clauses that turn into toll booths later.
One more thing before we start: many of these issues are not “evil.” They are often copy-paste clauses, or a lawyer trying to be “safe,” or an investor asking for something they got in another deal. The harm comes from what happens when your next lead investor reads it and says, “No.”
1) Participation rights that turn one investor into a permanent shadow
A common clause says: “Investor has the right to participate in future financings.”
That can be normal. The problem is how it is written.
If participation is written as a simple pro-rata right, it is often fine. It means: if they own 10% now, they can buy enough in the next round to keep 10%. Many later investors accept that.
But sometimes participation is written in a way that goes beyond pro-rata. It might allow them to buy more than their share. Or it might be tied to special price terms. Or it might be hard to remove. That changes the story.
Here is what happens in a later round. A new lead comes in and wants to take, say, 20% of the company. They build a round size that fits that goal. Then your early investor says, “I am participating for my full right, plus extra.” Now the round must get bigger, or the new lead must take less, or you must cut allocation from new investors the lead wants to bring in.
That is not a math issue. It is a control issue. The new lead wants to choose their syndicate. If your old terms force the lead to accept a passenger, the lead may push back hard.
The “quiet hurt” is that the clause can reduce demand for your next round. The lead feels like they cannot shape the deal, so they lower price or walk.
What you can do now: when you see participation language, ask a simple question: “Is this pro-rata only?” If the answer is not a clear yes, treat it as a future problem. You want participation to be pro-rata, and you want it to be tied to clear notice periods, and you want it to be lost if the investor does not show up when needed. In plain terms: you want rights that reward real support, not rights that sit forever.
2) Most favored nation that quietly freezes your ability to fix terms
Most favored nation, often called “MFN,” sounds fair. It sounds like: “If you give better terms to someone later, I get them too.”
In practice, MFN can make your next round messy, because it turns one negotiation into many.
Here is the problem. Seed rounds sometimes have multiple closings. Or you might do a small bridge. Or you might bring in a strategic investor. If one early investor has MFN, every later term you offer becomes a potential upgrade for them. That can include things like information rights, side letters, or special protections.
Later investors hate this because they cannot predict who else gets their terms. They want clean, simple, and contained rights. MFN breaks that.
It also creates a hidden trap for you. You might try to solve a small issue with a new investor by giving them a small special term. Then your MFN investor says, “Great, I want that too.” Now the special term becomes standard. Now you are carrying it into Series A.
What you can do now: if you see MFN, ask if it is limited. “Limited” means it only applies to a narrow set of terms and only for a short time. If it applies to everything, or has no end date, it can become a long-term handcuff. Many founders think MFN is harmless because it sounds like fairness. But the later effect is loss of flexibility.
3) Investor consent rights that turn daily work into permission slips
Consent rights are not all bad. Some are normal, like needing approval to sell the company or issue a new class of stock. But sometimes consent rights are drafted too wide, or triggered too easily, or given to one investor who is not aligned with your pace.
This is where later rounds get painful. New investors will ask: “Who can block us?” If the answer is “a single seed investor can block basic actions,” the deal slows down.
Here is a common example. Your term sheet might say you need investor consent to approve the annual budget. Sounds normal. But if “budget” is defined widely, or if the investor uses that power as leverage, you may end up negotiating your hiring plan with someone who does not live your business.
Another example: consent to take on debt. Robotics companies often use equipment leases, venture debt, or purchase order financing later. If your seed investor has a veto over “any debt,” you just gave them a lever over your growth plan.
In Series A, the new lead often wants to replace or reset these rights. If they cannot, they may require a lower valuation to compensate for the risk, or they may require you to get waivers first. Waivers take time. Time kills momentum.
What you can do now: scan for the section that lists “protective provisions,” “consent rights,” or “investor approvals.” Then read it like an operator, not a lawyer. Ask: “Will this force me to ask permission for normal actions?” If yes, narrow it. Tie approvals to major events, not routine management.
Also check who holds the right. If it is a “majority of preferred,” that is often more workable than “the holder of X’s shares.” The second version gives one person a “stop button.”
4) Board structure that looks fine… until your next lead wants a seat
Board terms can feel like a status symbol in seed. Someone asks for a board seat, and it feels like: “We are real now.”
But board structure is one of the first things a later lead investor looks at, because it affects control and speed.
If your seed round gives away too many seats, you may have no room later. Or you may end up with a board that is too large for an early-stage company. Too many voices means slow decisions. It can also mean politics.
Later, your Series A lead often expects a seat. If your board is already full, you now must renegotiate seats with existing members. That can get emotional. People do not like giving up seats. Even if they should.
The quiet hurt is not only the seat itself. It is the power attached to the seat. Some term sheets tie key approvals to board votes. So a board seat is not only advice. It becomes governance power.
What you can do now: aim for a board that stays small and flexible. Many healthy early boards are three people: two founders and one investor or independent. Then later you expand carefully. If you already have a five-person board at seed, you are borrowing trouble.
Also, check for board observer rights. Observers can be fine, but too many observers can make board meetings feel like a stage. That changes founder behavior. And it changes how free people feel to talk.
5) Dirty liquidation preferences that bend the math against you
Liquidation preference clauses decide who gets paid first in an exit. In seed, many founders accept a “1x non-participating” preference and move on. That is often fine.
The pain comes when the preference is participating, or stacks in ways that make later investors nervous, or creates a situation where common shareholders get little in a modest exit.
Participating preference is sometimes called “double dip.” It means the investor gets their money back first, then also shares in the remaining proceeds as if they converted. The effect is that they get a larger share of the exit than their ownership suggests.
Later investors care because preferences stack. If seed has a strong preference, and Series A wants one too, and Series B wants one too, you can end up with an “exit waterfall” that looks ugly. That can hurt morale, retention, and even acquisition interest, because buyers know your team may not be motivated.
Even if you are aiming big, later investors still ask: “What happens if the exit is $150M?” If the answer is that the team gets almost nothing, you have a problem.
What you can do now: learn the difference between “non-participating” and “participating.” If you do not know, ask your counsel to model it with simple numbers. And do not accept “it is market” as a full answer. Markets vary. Your deal is your deal.
Also check for “multiple liquidation preferences,” like 2x or 3x. Sometimes they show up in stressful rounds. They are harder to unwind later.
6) Redemption rights that turn your startup into a bank loan
Redemption rights sound technical. They usually say something like: “After X years, investor can require the company to repurchase shares.”
In a venture-backed startup, that is often unrealistic, because startups do not hold piles of cash. But that is the point: it creates leverage.
Later investors do not like redemption rights because it introduces a forced cash event. Even if it is unlikely, it becomes a risk item. Risk items slow down deals.
Also, redemption rights can create pressure on you during hard times. If growth dips, an investor might use redemption as a threat, even if they do not intend to use it. This is not a healthy dynamic.
What you can do now: if redemption is present, push to remove it, or at least push it far out and make it conditional on clear triggers. In most early venture deals, redemption is not needed. If someone insists, you should understand why.
7) Full ratchet anti-dilution that makes down rounds catastrophic
Anti-dilution clauses protect investors if the company later raises at a lower price. Some form of anti-dilution is common, but the type matters a lot.
Full ratchet is the harsh version. If you raise a down round, full ratchet resets the early investor’s conversion price to the new low price, no matter how small the down round is. The math can wipe founders out.
Later investors often refuse to lead a round if full ratchet is in place, because it can cause massive dilution and create conflict. Even if they agree to proceed, they will demand that full ratchet be removed, which means you must negotiate with the investors who hold it. Those investors might ask for extra shares or special terms to give it up.
This becomes a negotiation on top of a negotiation—when you are already under stress.
What you can do now: avoid full ratchet in early rounds. Weighted-average anti-dilution is more common and less destructive. Again, do not accept the clause just because it is buried in a standard template. This one can change your entire ownership story.
8) Pay-to-play that looks like “alignment” but can break relationships
Pay-to-play clauses say: if an investor does not invest in the next round, they lose certain rights, or their preferred converts to common.
This can be framed as fairness: “Support the company or step aside.” Sometimes it is helpful.
But it can also harm you later because it creates pressure on investors who might not be able to invest again, even if they still want to help. Some funds have limits. Some angels cannot follow on. In a later round, you might want these people to stay friendly and supportive. Pay-to-play can make them feel punished.
Also, in later rounds, a new lead might demand pay-to-play, and if you already have a version of it, the interactions can get complicated. You can end up with two different pay-to-play systems that clash.
What you can do now: if pay-to-play appears, check how harsh it is and when it triggers. You want something that encourages real support without creating a long list of unhappy early holders.
9) Side letters that create hidden rights nobody remembers
Side letters are small agreements that sit beside the main documents. They often cover information rights, special approvals, or promises about future behavior.
The issue is not that side letters exist. The issue is that they are easy to forget, and they do not always travel with the term sheet in people’s minds. Later, when diligence happens, they show up. And then the new lead asks: “Why does this one person have special terms?”
If the side letter gives them extra control, it becomes a governance issue. If it gives them extra economics, it becomes a fairness issue. If it gives them extra access to sensitive data, it becomes a risk issue.
What you can do now: keep side letters rare and simple. If you must use them, track them like you track your cap table. Assume a future investor will read them closely. Because they will.
10) IP and assignment language that scares deep tech investors
For robotics and AI companies, IP is often the asset. Term sheets and financing docs sometimes include clauses that touch IP in ways founders do not notice.
This can include: broad investor rights to inspect IP, clauses that limit where IP can be held, or requirements tied to “work for hire” and assignments that are incomplete.
Later investors will dig hard into IP. If your early docs are sloppy, they may require fixes. Fixes can include getting old contractors to sign assignments, cleaning up open-source compliance, or changing ownership structures.
This is where Tran.vc’s model is different: we invest up to $50,000 as in-kind patenting and IP services so you build clean, defensible IP early—before a later investor forces you to scramble. If you want to make later rounds smoother, you can apply anytime here: https://www.tran.vc/apply-now-form/
Term Sheet Clauses That Quietly Hurt Later Rounds
Why this matters more than you think
A seed term sheet can feel like a simple trade. You give a little. You get the money. You move on.
But later rounds do not look at your company the way you do. They look at risk. They look at control. They look at how hard it will be to lead your next round and still sleep at night.
Small clauses become big when a Series A lead tries to set clean terms. If your seed deal has hidden “extras,” the new lead will either demand you remove them or price the risk into the round.
That is why this topic is not legal theory. It is fundraising reality. If you want smoother later rounds, you must protect your future flexibility early.
How to read this article
I will walk through the clauses that cause the most trouble later. For each one, I will show what it looks like in plain words, why it becomes a problem, and how founders can push back without burning trust.
I will keep the language simple. I will keep the focus practical. This is about what happens in real rooms with real investors.
And when you want help building a strong IP base that later investors respect, Tran.vc can support you with up to $50,000 in in-kind patent and IP services. You can apply anytime here: https://www.tran.vc/apply-now-form/
Pro-Rata Rights That Quietly Become “Permanent Claims”
What pro-rata is supposed to be
A normal pro-rata right is simple. If an investor owns 10% today, they get the option to buy enough in the next round to keep 10%.
This is not strange. Many good investors ask for it, and many companies grant it. It can be healthy because it rewards investors who keep supporting you.
The trouble begins when the clause stops being “keep my share” and turns into “I can take more space than my share.”
How this hurts later rounds
A Series A lead is trying to shape the round. They want a specific ownership target. They also want room for a few new investors who add value.
If your seed investor has a right to buy more than pro-rata, it can crowd out the lead’s plan. That forces a hard choice: the round grows, the lead shrinks, or other investors get cut.
None of these outcomes feels good to the new lead. They start to wonder if you can run a clean process, or if every decision will require extra negotiation.
Over time, you lose something that matters a lot in fundraising: momentum.
What to push for in simple terms
When you review participation language, aim for a clean sentence: “Investor may participate up to their pro-rata share.”
If you see words that hint at “super pro-rata,” “oversubscription,” or special access to extra allocation, you should treat it as a future fight.
Also watch for rights that never expire. Rights that last forever can make every future round feel crowded, even when your company is doing well.
What to say in the room
You can be firm without being rude. A simple line works: “We are happy to offer standard pro-rata, but we need room for future leads to build the right syndicate.”
Most reasonable investors understand this. The ones who do not may be signaling how they will behave later.
MFN Clauses That Freeze Your Ability to Improve Anything
What MFN sounds like in plain language
MFN means “if you give someone a better deal later, you must upgrade me too.”
It sounds fair. It sounds like the investor is only protecting themselves from being treated worse than others.
But MFN can quietly turn your next financing step into a chain reaction.